KDventures´ portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer

STOCKHOLM, Sweden, 10 February 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that its portfolio company SVF Vaccines has appointed Raheleh Nassaji as Chief Executive Officer to lead the ...
The Pharma Letter

SVF Vaccines to take over Novakand in reverse acquisition

Swedish life sciences investor Karolinska Development (Nasdaq Stockholm: KDEV) says its portfolio company SVF Vaccines has agreed a reverse acquisition with Novakand Pharma (Nasdaq First North: NOVKAN ...
Taiwan News

Karolinska Development’s portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement

On December 22, 2025, SVF Vaccines and Novakand Pharma announced that the companies had entered a non-binding letter of intent (LOI) regarding a reverse acquisition. Following a successful, completed ...
PharmiWeb

Novakand Pharma applies for Nasdaq’s approval of continued listing of the combined company post a completed reverse takeover with SVF Vaccines

Novakand Pharma AB (publ) (“Novakand” or “the Company”) has previously reported that the Company has entered into a share purchase agreement with the shareholders of SVF Vaccines AB (“SVF”) for a ...
Nasdaq

SoftBank's third SPAC SVF Investment 2 files for a $200 million IPO

SVF Investment 2, the third blank check company formed by SoftBank targeting technology-enabled sectors, filed on Friday with the SEC to raise up to $200 million in an initial public offering. The San ...
insider.si.edu

“Smithsonian & SVF Biodiversity Preservation Project” Launched

The Smithsonian Conservation Biology Institute and the SVF Foundation announced July 24 the launch of the “Smithsonian & SVF Biodiversity Preservation Project” to strengthen rare and endangered ...